|
|
|
 |
Welcome to the FSRC Website!
July 11, 2013
RT Legislation Introduced in the House
CONGRATULATIONS RESPIRATORY THERAPISTS!!!
As many of you know, the AARC and your FSRC PACT representatives have been diligently working towards the introduction of the Medicare Respiratory Therapist Access Act in Congress. Our efforts have finally paid off, as Rep. John Lewis from Georgia introduced the bill into the House or Representatives on Monday, July 8, 2013. H.R. 2619 would significantly expand the ability of respiratory therapists to deliver vital selfmanagement services to Medicare patients in the physician office. Although this is a major step, it’s only the first. Your help is needed to assure that this bill is passed.
CLICK HERE TO MAKE THIS HAPPEN NOW.
|
|
** To view upcoming live CEU events, Click Here
|
** Instructions to View and Retrieve Certificates of Attendance at Live CEU Events, Click Here
|
|
UPCOMING CEU EVENTS
• Seminar at Sea CEU Cruise, Cozumel, Mexico - 8 CEUs -
April 10 - April 14, 2014
• Space Coast Cardiopulmonary Conference, Cocoa Beach, FL - Up to 14 CEUs -
April 17 - April 18, 2014
• Sunshine Seminar, Weston, FL - Up to 16 CEUs -
August 07 - August 08, 2014
|
|
Happenings in Respiratory Therapy
| Florida Board of Respiratory Care Board Meeting |
| |
- January 10, 2014 - Ponte Vedra Beach, FL
- April 11, 2014 - TBD
- July 11, 2014 - Ft Lauderdale, FL
- October 10, 2014 - Orlando, FL
|
| FSRC Upcoming Board Meeting(s) |
| |
|
|
Proposed State Budget Cuts May Impact Respiratory Jobs |
Get Involved!
Contact your Chapter Director and ask about the FSRC
Ambassador Program.
|
|
|
The Florida Society for Respiratory Care and/or any official agent has no real or perceived conflicts of interest relating to emergency preparedness and/or mechanical ventilation. All work relating to emergency preparedness and/or mechanical ventilation is rendered as advisory only and does not show preference to any one company or product. The organization or agent shall disclose any apparent conflicts regarding financial interest in a product or drug; and/or, any discussion regarding utilization of FDA drugs or devices not within the approved regulations prior to working in this capacity. Public disclosure of information relating to advice given to outside parties will be prefaced with disclosure information."
|
|
|
| 
